Association of Tumor Necrosis Factor α Inhibitor Use with Diagnostic Features and Mortality of Tuberculosis in the United States, 2010–2017

BACKGROUND: An elevated risk of tuberculosis (TB) disease in persons who have received tumor necrosis factor alpha inhibitor medications (TNF-α inhibitors) has been reported for nearly two decades, but clinical diagnostic features and outcomes of TB in this population remain poorly described. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Katrak, Shereen S, Li, Rongxia, Reynolds, Sue, Marks, Suzanne M, Probst, Jessica R, Chorba, Terence, Winthrop, Kevin, Castro, Kenneth G, Goswami, Neela D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801225/
https://www.ncbi.nlm.nih.gov/pubmed/35106318
http://dx.doi.org/10.1093/ofid/ofab641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801225/
https://www.ncbi.nlm.nih.gov/pubmed/35106318
http://dx.doi.org/10.1093/ofid/ofab641

Ejemplares similares